Analysis of IPOs with upcoming clinical trial milestones?
A list of candidates (like Chime or Revolut) and their recent profit margins?
The "Buy Now, Pay Later" giant went public in late 2025. Several major institutions like Deutsche Bank and Bank of America have since issued "Buy" ratings with price targets ranging from $48 to $51. recent ipos to buy
A payments processing leader with a private valuation near $159 billion. To help you decide which IPOs fit your portfolio,
A nuclear reactor manufacturer that debuted on the Nasdaq in April 2026 with a valuation of roughly $11.9 billion. Its IPO was significantly oversubscribed, reflecting strong appetite for energy infrastructure. Analysis of IPOs with upcoming clinical trial milestones
Healthcare biotech; currently trading ~47% above its initial offering.
These companies have recently gone public and are currently attracting significant investor interest: Several major institutions like Deutsche Bank and Bank
Technology services; holding a steady ~25% return from its mid-April debut. 💡 High-Value Upcoming Candidates